- Cardiovascular Systems, Inc. gained CE Mark for the Diamondback 360 Coronary Orbital Atherectomy System in January 2021. (OAS). The device has GlideAssist, which allows for better device tracking, repositioning, and removal, especially during difficult procedures, and may be used to treat a variety of calcium modalities. The company's product portfolio will be expanded as a result of the strategic move
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Directional Atherectomy, Orbital Atherectomy, Photo-Ablative (Laser) Atherectomy, Rotational Atherectomy and Support Devices), Application (Peripheral Vascular, Cardiovascular, Neurovascular and Others), End User (Hospitals and Surgical Centres, Ambulatory Care Centres, Research Laboratories and Academic Institutes and Others) - Industry Trends and Forecast to 2031
.
The Global Atherectomy Systems Market size was valued at USD 599.40 USD Million in 2023.
The Global Atherectomy Systems Market is projected to grow at a CAGR of 6.8% during the forecast period of 2024 to 2031.
The major players operating in the market include BD, Medtronic, Koninklijke Philips N.V., Cardinal Health, Cardiovascular Systems , Boston Scientific Corporation, and others-.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
